CVE-2022-30604
MEDIUMCVSS 6.1/10EPSS 0.55%
Last modified
CVE-2022-30604 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. Cross-site scripting vulnerability in the specific parameters of Cybozu Office 10.0.0 to 10.8.5 allows a remote attacker to inject an arbitrary script via unspecified vectors.. EPSS estimates a 0.55% chance of exploitation in the next 30 days.
Description
Cross-site scripting vulnerability in the specific parameters of Cybozu Office 10.0.0 to 10.8.5 allows a remote attacker to inject an arbitrary script via unspecified vectors.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Cybozu | Office | >= 10.0.0, <= 10.8.5 |
References
- https://cs.cybozu.co.jp/2022/007584.htmlVendor Advisory
- https://jvn.jp/en/jp/JVN20573662/index.htmlThird Party Advisory, VDB Entry
- https://cs.cybozu.co.jp/2022/007584.htmlVendor Advisory
- https://jvn.jp/en/jp/JVN20573662/index.htmlThird Party Advisory, VDB Entry
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-30604?
Cross-site scripting vulnerability in the specific parameters of Cybozu Office 10.0.0 to 10.8.5 allows a remote attacker to inject an arbitrary script via unspecified vectors.
How severe is CVE-2022-30604?
CVE-2022-30604 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.55% probability of exploitation in the next 30 days.
How do I fix CVE-2022-30604?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2022-30604?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
